Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8) is an **accessory subunit** of mitochondrial Complex I, the first and largest enzyme complex of the electron transport chain. It is **not directly involved in catalysis**, but is essential for structural integrity and proper function of Complex I, which catalyzes electron transfer from NADH to ubiquinone coupled with proton translocation across the mitochondrial inner membrane. This process is crucial for ATP generation by oxidative phosphorylation[5][6][1][4][2]. Defects in Complex I, including its accessory subunits such as NDUFA8, are linked to various mitochondrial diseases and are implicated in some neurodegenerative diseases[1][5].
Inhibition of electron transfer from NADH to ubiquinone at Complex I (i.e., inhibition of NADH:ubiquinone oxidoreductase impairs mitochondrial respiration)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8).